PD10-07 QUALITY OF LIFE OF PROSTATE CANCER (PCA) PATIENTS WITH TESTOSTERONE DEFICIENCY SYMPTOMS (TDS) BEFORE INITIATION OF GONADOTROPIN-RELEASING HORMONE (GNRH) AGONIST THERAPY, SUBGROUP ANALYSIS OF EQUINOXE STUDY

Stéphane Droupy,Marie-Hélène Colson,Nathalie Pello Leprince Ringuet,Valérie Perrot,Aurélien Descazeaud

PD10-07 QUALITY OF LIFE OF PROSTATE CANCER (PCA) PATIENTS WITH TESTOSTERONE DEFICIENCY SYMPTOMS (TDS) BEFORE INITIATION OF GONADOTROPIN-RELEASING HORMONE (GNRH) AGONIST THERAPY, SUBGROUP ANALYSIS OF EQUINOXE STUDY

2020

Stéphane Droupy
Marie-Hélène Colson
Nathalie Pello Leprince Ringuet
Valérie Perrot
Aurélien Descazeaud

INTRODUCTION AND OBJECTIVE:Both PCa and TDS risk increase with age. Patients may therefore suffer from both conditions, and their quality of life (QoL) be reduced. Unexpectedly, multivariate analys...

Keywords:

Quality of life
Urology
Agonist
Internal medicine
Gonadotropin-releasing hormone
Medicine
Subgroup analysis
Endocrinology
testosterone deficiency
Prostate cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations